Genomate Health Inc, a global leader in precision oncology, announces its strategic partnership with Intelligene Healthcare Pvt Ltd, marking a significant step towards advancing personalized cancer care in India.

Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.

Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence.

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients

John Tarantino joins hands with Iylon Precision Oncology to help cancer patients around the globe.

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry

The research done by Imagene and Sheba Medical Center was recently published in 'Modern Pathology' journal.

The research will be presented at the European Congress of Pathology (ECP) 2022